FHCLX
Select Health Care Portfolio
Fidelity Select Portfolios
Expense ratio1
0.91%
Net assets2
$6.20B
Holdings2
125
Category
US Equity
2025 return3
14.40%

Investment objective & strategy

As of March 5, 2026 · prospectus

Objective. Health Care Portfolio seeks capital appreciation.

Strategy. Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in … Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are committed to, derived from, or related to the designated business activity or activities, or (ii) whether a third party has given the company an industry or sector classification consistent with the designated business activity or activities. Whether a company is principally engaged in the designated business activity or activities can be determined under any of these factors. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in the fund's 80% policy, consistent with the fund's investment policies and limitations with respect to investments in derivatives. Normally investing primarily in common stocks. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Top holdings

As of Feb. 28, 2026 · N-PORT
SecurityTickerValue% of fund
LILLY ELI and CO $429.21M 6.93%
DANAHER CORP $396.00M 6.39%
BOSTON SCIENTIFIC CORP $372.72M 6.01%
JOHNSON&JOHNSON $347.80M 5.61%
ABBVIE INC $264.57M 4.27%
Fidelity Securities Lending Cash Central Fund $224.55M 3.62%
Ascendis Pharma A/S $167.19M 2.70%
UCB SA $160.98M 2.60%
GILEAD SCIENCES INC $160.87M 2.60%
MERCK & CO $158.49M 2.56%
View all holdings →

Allocation by sector

As of February 28, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Nov 30, 2025 → Feb 28, 2026
Opened
17
Exited
20
Increased
37
Decreased
34
Unchanged
37

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
VIP Health Care Portfolio 90% 0.59%
Fidelity Advisor Health Care Fund · FACDX, FHCCX, FACTX, FHCIX, FIKCX 88% 0.56%
Fidelity Disruptive Medicine ETF · FMED 53% 0.50%
View all similar funds →

Advisers

As of February 28, 2025 · N-CEN
FirmRole
FMR Investment Management (UK) Limited Sub-adviser
Fidelity Management & Research (Japan) Limited Sub-adviser
Fidelity Management & Research (Hong Kong) Limited Sub-adviser
Fidelity Management & Research Company LLC Adviser

Footnotes

  1. Expense ratio as of March 5, 2026, from the fund's prospectus.
  2. Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
  3. Total return for calendar year 2025, before tax and after fund expenses. As reported in the fund's prospectus performance bar chart.

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.